{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/61a48e6defe03000141336e0/6203c850f24cf60014e64220?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"mRNA Pharmacology Optimization","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/undefined/1638174257576-b93102ad18d95cb412bbf011fb35a99e.jpeg?height=200","description":"<p>In vitro transcribed (IVT) messenger RNA (mRNA) has recently come into focus as a potential new drug class to deliver genetic information. Such <a href=\"https://mrna.creative-biolabs.com/mrna-pharmacology-optimization.htm\" rel=\"noopener noreferrer\" target=\"_blank\">synthetic mRNA</a> can be engineered to transiently express proteins by structurally resembling natural mRNA.</p>","author_name":"Jerry Carter"}